Key Partnership with Beta Bionics Xeris Pharmaceuticals has partnered with Beta Bionics to develop a dual-hormone pump for diabetes. This collaboration presents an opportunity for sales teams to explore joint offerings that cater to diabetes management solutions, potentially expanding market reach and boosting sales.
Funding and Financial Growth With recent financing of $200M and revenue ranging between $50M to $100M, Xeris Pharmaceuticals displays financial stability and growth potential. Sales development representatives can capitalize on this financial strength to negotiate larger deals, secure long-term partnerships, and drive revenue growth for the company.
Expanded Product Development Xeris Pharmaceuticals is actively developing advanced products such as a glucagon product and innovative injection solutions. Sales professionals can leverage these upcoming product releases to engage with existing and potential clients, showcasing the company's commitment to innovation and expanding product portfolio to drive sales.
CEO Succession Plan Xeris Pharmaceuticals announced a CEO succession plan, marking the retirement of Paul Edick. This leadership transition presents an opportune time for sales representatives to connect with the new CEO, establish fresh relationships, and align sales strategies with the company's evolving vision, potentially opening doors to new business opportunities.
Market Expansion through Partnerships Through strategic collaborations with companies like Regeneron, Xeris Pharmaceuticals is venturing into new markets and diversifying its product offerings. Sales development representatives can use these partnerships to access new customer segments, explore cross-selling opportunities, and enhance market penetration, driving sales growth for the company.
560
$50M$100M
3.3K$100M$1B
87K$1B
103K$1B
73K$1B
46K$1BXeris Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, React, Open Graph, and more. Explore Xeris Pharmaceuticals, Inc.'s tech stack below.
| Xeris Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@xerispharma.com | 96% |
| Last@xerispharma.com | 2% |
| FMiddleLast@xerispharma.com | 1% |
| FiLast@xerispharma.com | 1% |
Pharmaceutical ManufacturingIllinois, United States201-500 Employees
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
Company Overview
Funding & FinancialsXeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.
Xeris Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M
Funding & FinancialsXeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.
Xeris Pharmaceuticals, Inc.'s revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com